Anti-CCP reference ranges
| Result | Interpretation |
|---|---|
| Negative (<20 U/mL) | RA less likely (but not excluded) |
| Weakly positive (20–39 U/mL) | Borderline — repeat or correlate with symptoms |
| Positive (≥40 U/mL) | Strongly suggests rheumatoid arthritis |
| Strongly positive (≥3x upper limit) | High specificity for RA — also predicts more erosive disease |
Why anti-CCP is more useful than rheumatoid factor
Specificity advantage
Anti-CCP antibodies are present in about 70–80% of RA patients — similar to rheumatoid factor (RF). However, anti-CCP is far more specific: it is positive in <2% of healthy individuals, compared to 5% for RF. Anti-CCP can also be positive years before RA symptoms develop, making it useful for early diagnosis. A patient who is anti-CCP positive and RF positive has nearly a 99% chance of having RA.
Anti-CCP and disease prognosis
Anti-CCP positivity predicts more aggressive, erosive rheumatoid arthritis. People with high anti-CCP levels are more likely to develop joint damage visible on X-ray, and early aggressive treatment (DMARDs such as methotrexate) is more strongly indicated.
Questions to ask your doctor
- Is my anti-CCP positive, and how strongly positive?
- Am I also RF positive?
- Should I start DMARD treatment early?
- Do I need X-rays of my hands and feet to check for joint damage?
Medical Disclaimer: For educational purposes only. Always consult a qualified healthcare professional for diagnosis and treatment.